Cibus Inc. (CBUS)
1.97
0.04 (2.07%)
Apr 28, 2025, 1:54 PM - Market open
2.07% (1D)
| Bid | 1.88 |
| Market Cap | 68.09M |
| Revenue (ttm) | 4.26M |
| Net Income (ttm) | -251.39M |
| EPS (ttm) | -10.83 |
| PE Ratio (ttm) | -0.18 |
| Forward PE | -1.38 |
| Analyst | Buy |
| Ask | 1.95 |
| Volume | 46,132 |
| Avg. Volume (20D) | 159,237 |
| Open | 1.97 |
| Previous Close | 1.93 |
| Day's Range | 1.91 - 1.99 |
| 52-Week Range | 1.40 - 19.56 |
| Beta | 1.84 |
About CBUS
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production result...
Industry Biotechnology
Sector Healthcare
IPO Date Jul 20, 2017
Employees 157
Stock Exchange NASDAQ
Ticker Symbol CBUS
Website https://www.cibus.com
Analyst Forecast
According to 3 analyst ratings, the average rating for CBUS stock is "Buy." The 12-month stock price forecast is $23.5, which is an increase of 1092.89% from the latest price.
Stock ForecastsNext Earnings Release
Cibus Inc. is scheduled to release its earnings on May 8, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-5.65%
Cibus shares are trading lower following the annou...
Unlock content with
Pro Subscription
5 months ago
+8.9%
Cibus shares are trading higher. HC Wainwright & Co. reiterated a Buy rating on the stock.
